United States · FDA National Drug Code directory

Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
58602-807_1d7ea7a2-9e1f-4fff-9a93-6cd7a0663ac5
Product NDC
58602-807
Form
TABLET, FILM COATED, EXTENDED RELEASE
Composition / generic term
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride
Labeler
Aurohealth LLC
Marketing category
ANDA
Marketing start / end (source format)
20171030
Source listing expiry
20271231

Source-listed ingredients

  • FEXOFENADINE HYDROCHLORIDE — 60 mg/1
  • PSEUDOEPHEDRINE HYDROCHLORIDE — 120 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 2 BLISTER PACK in 1 CARTON (58602-807-67) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 58602-807-67
  • 1 BLISTER PACK in 1 CARTON (58602-807-83) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 58602-807-83
  • 3 BLISTER PACK in 1 CARTON (58602-807-84) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 58602-807-84

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride — United States | Molindra Medicines